Adam F is like all "news" reporters these days - they all have an agenda, and his agenda is paid for by the hedge funds that short biotech stocks. When in doubt, follow the money.
regarding the article today on amrn you should google Larry Husten the writer of todays article and Adam Feuerstein and see all the connections going back years between the 2 not only on AMRN but other stocks as well.
You must also wonder how generics will be a threat as previous articles said every generic and everyone will want to make Vascepa. You have to wonder about these contradictions as why would anyone want to make Vascepa since its just fish oil. lol...Comical!!
Market Data 
Markets 
AI
